Entresto (sacubitril and valsartan), from the drug manufacturer Novartis, can be used to treat patients with heart failure and reduced ejection fraction to reduce the chance of cardiovascular death and hospitalization for heart failure. Entresto relaxes blood vessels, improves blood flow, and reduces strain on the heart. Entresto is a